19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace.

SCAMHC serves all individuals regardless of inability to pay. Discounts for essential services are offered based on family size and income. For more information, contact (334) 222-2523 or our 24/7 Helpline at 1-877-530-0002.



powered by centersite dot net
Depression: Depression & Related Conditions
Basic Information
Introduction and Types of Depressive DisordersRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferences
More InformationTestsLatest News
Treating Depression Could Lengthen Lung Cancer Patients' LivesDepression in Early Life May Up Dementia Risk LaterFirst Year of Pandemic Saw Depression Rates Triple'Personalized' Brain Zaps May Ease Tough-to-Treat DepressionStopping Antidepressants Raises Relapse RiskDepression During Pregnancy Raises Risk of Mood Disorder in KidsIs Insulin Resistance a Recipe for Depression?Depression During Menopause: How to Spot It and Treat ItCould You Help Prevent a Suicide? Know the Warning SignsDepression Can Be a Killer for People With MSKetamine Appears Safe as Therapy for Tough-to-Treat DepressionThe Bigger the City, the Lower the Depression Rates?Shock Therapy Safe, Effective for Tough-to-Treat DepressionDepression Plagues Many Coal Miners With Black Lung Disease1 in 4 People With Anxiety, Depression Couldn't Get Care During PandemicBody's 'Signals' May Feel Different in People With Anorexia, DepressionDads of 'Preemie' Babies Can Be Hit by DepressionCould Fish Oil Supplements Help Fight Depression?Treating Teachers' Depression Could Boost Young Students' Grades: Study'Laughing Gas' Shows Promise Against Tough-to-Treat Depression'Early Birds' May Have Extra Buffer Against DepressionTennis Star Naomi Osaka's 'Time Out' Highlights Common, Crippling Mental Health IssueMassive Gene Study Probes Origins of DepressionAHA News: Link Between Depression and Heart Disease Cuts Both WaysAHA News: Depression and Anxiety Linked to Lower Levels of Heart Health in Young AdultsDepression Even More Common With Heart Failure Than CancerNothing to Sniff at: Depression Common for People With COVID-Linked Smell LossPandemic Is Leading to More Depression for Pregnant Women Worldwide: Study'Non-Drug' Approaches Can Fight Depression in People With DementiaHalf of COVID Survivors Struggle With Depression: StudyDepression Often Follows Stroke, and Women Are at Higher RiskAs Lockdowns Cut Into Exercise Time, Depression Rates Are RisingCommon Antidepressants Won't Raise Risk for Bleeding Strokes: StudyFeeling SAD? Here Are Ways to Ease Winter BluesTreating Mom's Postpartum Depression Could Help Baby's Brain, TooDepression in Youth Ups Odds for Adult Illnesses: StudyToo Much Social Media Time Could Raise Risk of DepressionAHA News: Certain Antidepressants Might Increase Stroke Risk for Young Adults With PTSDCOVID Fuels Depression Among Pregnant Women, New Moms'Body Issues' Raise Depression Risks for TeensCoping With Lockdown Loneliness During the HolidaysAHA News: People With Depression Fare Worse in Heart Health StudyTwo Key Lifestyle Factors May Ward Off DepressionBirth Control Pill Won't Raise Depression RiskDepression Has Strong Ties to Stroke, Study FindsFor Some Women, Postpartum Depression Lingers for YearsPreventive Intervention for Premature Infants Effective
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Bipolar Disorder
Addictions: Alcohol and Substance Abuse
Pain Management

'Laughing Gas' Shows Promise Against Tough-to-Treat Depression

HealthDay News
by By Alan Mozes HealthDay Reporter
Updated: Jun 10th 2021

new article illustration

THURSDAY, June 10, 2021 (HealthDay News) -- When antidepressants fail to rein in hard-to-treat depression, the common anesthetic most know as "laughing gas" might be a safe and effective alternative, new research suggests.

The finding follows work with 28 patients struggling with "treatment-resistant major depression," a severe condition that investigators say affects about one-third of all patients — an estimated 17 million American adults — who develop major depressive disorder.

For such patients, antidepressants often fail to provide relief. But following three one-hour laughing gas inhalation sessions spread across three months, 85% of patients had significant depression relief that endured weeks post-treatment.

"Laughing gas is nitrous oxide, one of the oldest and most commonly used anesthetics," explained study author Peter Nagele, chair of anesthesia and critical care at the University of Chicago.

"And we found that laughing gas, at a much lower concentration than is used, for instance, during dental procedures, can help patients with difficult-to-treat depression," Nagele said.

Between 2016 and 2019, Nagele's team tried out two laughing gas formulations: one at a level of 50% nitrous oxide and one at a level of 25%.

Previous investigations had already demonstrated an antidepressant benefit at the higher level. But those efforts only assessed a post-treatment benefit of 24 hours. And patients exposed to the higher dose commonly experienced side effects, including nausea, sedation and or "mild dissociation," a kind of daydreaming experience.

In the latest study, patients were between the ages of 18 and 75. All were told to continue their usual depression care and maintain their existing antidepressant regimen.

About one-third were exposed to three sessions of 50% nitrous oxide inhalation treatment, one-third were given a 25% nitrous oxide inhalation treatment and one-third were given an oxygen inhalation treatment that contained no laughing gas.

Treatment was delivered via a standard anesthesia face mask, and all were monitored for up to one hour post-treatment.

After four patients withdrew from the study, results were drawn from 20 patients who completed all three inhalation sessions and four patients who completed at least one treatment.

The investigators found that both formulations offered significant depression control. In fact, just a single session (at either dosage) provided "rapid" depression control among patients, the team noted.

Depression control also appeared to grow in effect over time, enduring up to a month post-treatment among some of the patients. At the three-month mark, the team found that 85% of patients had symptom improvement and 40% were found to be in depression remission.

Perhaps just as importantly, the team also found that "using a lower concentration of nitrous oxide also reduced the risk of side effects fourfold."

So, how exactly does laughing gas tamp down depression?

"The mechanism of how nitrous oxide exerts antidepressant effects is unknown, and is likely different from how it induces sedation and unconsciousness and also pain relief," Nagele said. "Having said this, the most widely accepted theory is that nitrous oxide blocks a specific receptor in the brain called NMDA-receptor, which is also considered the main mechanism for [the medication] ketamine."

Ketamine is a class III scheduled drug. While hospitals traditionally deploy the drug as an anesthetic, it's also been explored for its potential as an "off-label" treatment for depression.

According to Steven Hollon, a professor of psychology at Vanderbilt University in Brentwood, Tenn., "Ketamine is the hottest thing going" in the world of alternative depression treatment research.

Hollon was not involved in the new study, and acknowledged that he is not well-versed in the specifics of nitrous oxide depression treatment research. Still, he stressed that the finding "suggests a common mechanism" with ketamine. And he characterized Nagele's work as "a most impressive 'proof-of-concept' study that would make me want to see the matter pursued."

The depression control seen among those patients exposed to low-dose laughing gas was "as good or better than you would hope to get in a placebo-controlled trial with antidepressant medications, and these are treatment-resistant patients. [It's] quite impressive," Hollon noted.

"If they came forward with this as pilot data, I would fund them for a major trial," he added. "These are very promising findings."

The report by Nagele and his colleagues was published in the June 9 issue of Science Translational Medicine.

More information

There's more on treatment-resistant depression at the Mayo Clinic.

SOURCES: Peter Nagele, chair, anesthesia and critical care, department of anesthesia and critical care, University of Chicago; Steven Hollon, PhD, professor, psychology, Vanderbilt University, Brentwood, Tenn.; Science Translational Medicine, June 9, 2021